763 related articles for article (PubMed ID: 29740437)
1. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
2. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
3. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
[TBL] [Abstract][Full Text] [Related]
5. Canine Natural Killer Cell-Derived Exosomes Exhibit Antitumor Activity in a Mouse Model of Canine Mammary Tumor.
Lee J; Lee SA; Gu NY; Jeong SY; Byeon JS; Jeong DU; Ouh IO; Lee YH; Hyun BH
Biomed Res Int; 2021; 2021():6690704. PubMed ID: 34527741
[TBL] [Abstract][Full Text] [Related]
6. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
Zhang C; Burger MC; Jennewein L; Genßler S; Schönfeld K; Zeiner P; Hattingen E; Harter PN; Mittelbronn M; Tonn T; Steinbach JP; Wels WS
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26640245
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity.
Mohammadi F; Hashemi ZS; Forooshani RS; Alizadeh S
Biomed Res Int; 2022; 2022():5396628. PubMed ID: 36060136
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model.
Zhu L; Li XJ; Kalimuthu S; Gangadaran P; Lee HW; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2017; 8():816. PubMed ID: 28785259
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of glioblastoma cells for immunotherapy.
Jung TY; Choi YD; Kim YH; Lee JJ; Kim HS; Kim JS; Kim SK; Jung S; Cho D
Anticancer Res; 2013 Jun; 33(6):2525-33. PubMed ID: 23749904
[TBL] [Abstract][Full Text] [Related]
10. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.
Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S
J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272
[TBL] [Abstract][Full Text] [Related]
11. Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.
Kim HY; Min HK; Song HW; Yoo A; Lee S; Kim KP; Park JO; Choi YH; Choi E
Drug Deliv; 2022 Dec; 29(1):2897-2911. PubMed ID: 36068970
[TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
Lee SJ; Kang WY; Yoon Y; Jin JY; Song HJ; Her JH; Kang SM; Hwang YK; Kang KJ; Joo KM; Nam DH
BMC Cancer; 2015 Dec; 15():1011. PubMed ID: 26704632
[TBL] [Abstract][Full Text] [Related]
13. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
14. Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.
Wang L; Wang Y; Quan J
Hum Cell; 2020 Jul; 33(3):582-589. PubMed ID: 32449114
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
Tran TA; Kim YH; Duong TH; Thangaraj J; Chu TH; Jung S; Kim IY; Moon KS; Kim YJ; Lee TK; Lee CW; Yun H; Lee JJ; Lee HJ; Lee KH; Jung TY
Front Immunol; 2022; 13():1009484. PubMed ID: 36703992
[TBL] [Abstract][Full Text] [Related]
17. [miR-30e-3p in natural killer cell-derived exosomes inhibits the proliferation and invasion of human esophageal squamous carcinoma cells].
Sun M; Li H; Feng B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):295-302. PubMed ID: 37087546
[TBL] [Abstract][Full Text] [Related]
18. Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells.
Liu ZM; Wang YB; Yuan XH
Asian Pac J Cancer Prev; 2013; 14(1):309-14. PubMed ID: 23534743
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
20.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
